Fidelta announces drug discovery agreement with Galapagos

12th December 2018 Fidelta announces drug discovery agreement with Galapagos Zagreb, Croatia, 12th – Fidelta Ltd is pleased to announce that it has signed an integrated drug discovery agreement with Galapagos based on Fidelta’s macrocyclic platform. Under the terms of the agreement, Galapagos will leverage Fidelta’s extensive expertise in macrocyclic drug discovery to further strengthen … Continued

World Preclinical Congress

The World Preclinical Congress will take place in Lisbon on 27th-30th of November 2018. The event is driven by the willingness to bring together scientists from pharma/biotech companies and academia with a particular focus on highlighting the various challenges and opportunities that exist in early drug discovery. Fidelta is very excited to take an active … Continued

Fidelta.eu

Fidelta.eu